193 related articles for article (PubMed ID: 32414285)
1. Can we prevent ovarian cancer?
Aus AT
Ceska Gynekol; 2020; 85(1):49-58. PubMed ID: 32414285
[TBL] [Abstract][Full Text] [Related]
2. ACOG Committee Opinion No. 774: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
Obstet Gynecol; 2019 Apr; 133(4):e279-e284. PubMed ID: 30913199
[TBL] [Abstract][Full Text] [Related]
3. The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage.
Naumann RW; Hughes BN; Brown J; Drury LK; Herzog TJ
Am J Obstet Gynecol; 2021 Oct; 225(4):397.e1-397.e6. PubMed ID: 33798477
[TBL] [Abstract][Full Text] [Related]
4. Salpingectomy for the Risk Reduction of Ovarian Cancer: Is It Time for a Salpingectomy-alone Approach?
Boerner T; Long Roche K
J Minim Invasive Gynecol; 2021 Mar; 28(3):403-408. PubMed ID: 33038519
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic salpingectomy for the prevention of ovarian cancer: Who should we target?
Kotsopoulos J; Narod SA
Int J Cancer; 2020 Sep; 147(5):1245-1251. PubMed ID: 32037528
[TBL] [Abstract][Full Text] [Related]
6. A model for estimating ovarian cancer risk: application for preventive oophorectomy.
Giannakeas V; Sopik V; Shestopaloff K; Iqbal J; Rosen B; Akbari M; Narod SA
Gynecol Oncol; 2015 Nov; 139(2):242-7. PubMed ID: 26341709
[TBL] [Abstract][Full Text] [Related]
7. ACOG Committee Opinion No. 774 Summary: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
Obstet Gynecol; 2019 Apr; 133(4):842-843. PubMed ID: 30913193
[TBL] [Abstract][Full Text] [Related]
8. Risk-reducing Bilateral Salpingo-oophorectomy: Assessing the Incidence of Occult Ovarian Cancer and Surgeon Adherence to Recommended Practices.
Newcomb LK; Toal CT; Rindos NB; Wang L; Mansuria SM
J Minim Invasive Gynecol; 2020; 27(7):1511-1515. PubMed ID: 31927044
[TBL] [Abstract][Full Text] [Related]
9. [Exclusive salpingectomy or prophylactic salpingo-oophorectomy? Critical analysis of the latest French guidelines].
Chene G; Lamblin G
Gynecol Obstet Fertil Senol; 2018 Jan; 46(1):1-3. PubMed ID: 29203396
[No Abstract] [Full Text] [Related]
10. Towards Prevention of Ovarian Cancer.
Ali AT
Curr Cancer Drug Targets; 2018; 18(6):522-537. PubMed ID: 29295697
[TBL] [Abstract][Full Text] [Related]
11. Interventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Postition Statement.
Pérez-López FR; Ceausu I; Depypere H; Kehoe S; Lambrinoudaki I; Mueck A; Senturk LM; Simoncini T; Stevenson JC; Stute P; Rees M
Maturitas; 2017 Jun; 100():86-91. PubMed ID: 28389043
[TBL] [Abstract][Full Text] [Related]
12. Preventing Ovarian Cancer in High-risk Women: One Surgery at a Time.
Swanson CL; Bakkum-Gamez JN
Clin Obstet Gynecol; 2020 Mar; 63(1):64-73. PubMed ID: 31764001
[TBL] [Abstract][Full Text] [Related]
13. Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: a cohort study from British Columbia, Canada.
Hanley GE; Kwon JS; Finlayson SJ; Huntsman DG; Miller D; McAlpine JN
Am J Obstet Gynecol; 2018 Aug; 219(2):172.e1-172.e8. PubMed ID: 29852159
[TBL] [Abstract][Full Text] [Related]
14. Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status.
Manchanda R; Abdelraheim A; Johnson M; Rosenthal AN; Benjamin E; Brunell C; Burnell M; Side L; Gessler S; Saridogan E; Oram D; Jacobs I; Menon U
BJOG; 2011 Jun; 118(7):814-24. PubMed ID: 21392246
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic salpingectomy and prophylactic salpingoophorectomy for adnexal high-grade serous epithelial carcinoma: A reappraisal.
Oliver Perez MR; Magriñá J; García AT; Jiménez Lopez JS
Surg Oncol; 2015 Dec; 24(4):335-44. PubMed ID: 26690823
[TBL] [Abstract][Full Text] [Related]
16. Current Updates on Salpingectomy for the Prevention of Ovarian Cancer and Its Practice Patterns Worldwide.
Dhakal S; Zheng YX; Yi XF
Chin Med Sci J; 2017 Sep; 32(3):185-192. PubMed ID: 28956746
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers.
Kwon JS; Tinker A; Pansegrau G; McAlpine J; Housty M; McCullum M; Gilks CB
Obstet Gynecol; 2013 Jan; 121(1):14-24. PubMed ID: 23232752
[TBL] [Abstract][Full Text] [Related]
18. The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecologic disease in the United States.
Mandelbaum RS; Adams CL; Yoshihara K; Nusbaum DJ; Matsuzaki S; Matsushima K; Klar M; Paulson RJ; Roman LD; Wright JD; Matsuo K
Am J Obstet Gynecol; 2020 Nov; 223(5):721.e1-721.e18. PubMed ID: 32360846
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of salpingectomy at hysterectomy to reduce the risk of epithelial ovarian cancer: a systematic review.
Darelius A; Lycke M; Kindblom JM; Kristjansdottir B; Sundfeldt K; Strandell A
BJOG; 2017 May; 124(6):880-889. PubMed ID: 28190289
[TBL] [Abstract][Full Text] [Related]
20. A new strategy for prophylactic surgery in BRCA women: Combined mastectomy and laparoscopic salpingo-oophorectomy with immediate reconstruction by double DIEP flap.
Hunsinger V; Marchac AC; Derder M; Hivelin M; Lecuru F; Bats AS; Lantieri L
Ann Chir Plast Esthet; 2016 Jun; 61(3):177-82. PubMed ID: 26946931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]